Barclays
CBST

Barclays’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Barclays’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-253,100
Closed -$25.3M – 7532
2014
Q4 		$25.3M Buy
253,100
+243,000
+2,406% +$18.9M 0.02% 642
2014
Q3 		$667K Buy
10,100
+3,400
+51% +$223K ﹤0.01% 3704
2014
Q2 		$462K Sell
6,700
-9,500
-59% -$646K ﹤0.01% 4055
2014
Q1 		$1.18M Sell
16,200
-1,223,900
-99% -$91.3M ﹤0.01% 3061
2013
Q4 		$84.3M Sell
1,240,100
-942,900
-43% -$61M 0.09% 192
2013
Q3 		$138M Buy
2,183,000
+857,700
+65% +$51.8M 0.16% 87
2013
Q2 		$64M Buy
+1,325,300
New +$65.1M 0.08% 203

Barclays's CBST Position: Q1 2015 in Review

Barclays sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 516,050 shares — an estimated $51.6M sold.

Barclays first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $62.1M in Q4 2013. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

  • Barclays reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Barclays sold 516,050 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $51.6M.
  • Barclays first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • Barclays's CUBIST PHARMACEUTICALS INC position peaked at $62.1M in Q4 2013.
  • 0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on Barclays's 13F filing for Q1 2015, filed 14 May 2015.